Exporting trusted Medicine Worldwide

Email Address

sales@visions-ent.com

Phone Number

+92-335-4868645

Our Location

Marriott Road , Denso Hall , Karachi.

Category

Novodol Low Dose Contraceptive Tablets

Novodol is a dependable, low-dose oral contraceptive pill formulated for effective family planning and pregnancy prevention. It utilizes a combined hormonal formulation of Levonorgestrel and Ethinylestradiol Tablets USP alongside Ferrous Fumarate Tablets BP to provide dual benefits of birth control and iron supplementation. This pack contains a total of 28 tablets spread across 2 blisters (14 tablets per strip), making it an accessible and structured option for daily reproductive health management.

Description

Novodol, distributed under the trusted “Sabz Sitara” (Green Star) social marketing initiative, is a combined oral contraceptive pill (COCP) designed to safely manage family planning.

  • Levonorgestrel and Ethinylestradiol USP: These active low-dose hormones work primarily by preventing ovulation, altering the cervical mucus to block sperm penetration, and changing the uterine lining to inhibit implantation.

  • Ferrous Fumarate BP: The pack includes iron-supplement tablets intended to be taken during the reminder/inactive pill phase. This helps replenish iron levels lost during menstrual bleeding, preventing anemia and supporting general vitality.

Low-Dose Formulation for Enhanced Comfort The “Low Dose” design of Novodol ensures optimal contraceptive efficacy while minimizing common hormone-related side effects, such as nausea or headaches, making it highly suitable for long-term daily routine use. The 28-tablet layout supports a continuous, habit-forming daily routine that prevents accidental missed days. As a key product in community reproductive healthcare, Novodol empowers women with a highly reliable, accessible, and health-conscious family planning solution.

Reviews

There are no reviews yet.

Be the first to review “Novodol Low Dose Contraceptive Tablets”

Your email address will not be published. Required fields are marked *